Twist Bioscience (TWST) Other Non-Current Liabilities (2018 - 2026)

Twist Bioscience (TWST) has reported Other Non-Current Liabilities for 9 consecutive years, with $6.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non-Current Liabilities rose 842.3% year-over-year to $6.5 million in Q2 2026; TTM through Jun 2026 was $6.5 million, a 842.3% increase from a year earlier, with the FY2025 full-year figure at $747000.0, up 83.54% from the prior year.
• Other Non-Current Liabilities was $6.5 million for Q2 2026 at Twist Bioscience, up from $746000.0 in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $8.1 million in Q1 2022 and troughed at $60000.0 in Q3 2022.
• A 5-year average of $1.3 million and a median of $475000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
• The widest YoY moves for Other Non-Current Liabilities: up 1830.57% in 2022, down 99.79% in 2022.
• Over 5 years, Other Non-Current Liabilities stood at $60000.0 in 2022, then soared by 691.67% to $475000.0 in 2023, then fell by 14.32% to $407000.0 in 2024, then jumped by 82.06% to $741000.0 in 2025, then surged by 774.9% to $6.5 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $6.5 million (Q2 2026), $746000.0 (Q1 2026), and $741000.0 (Q4 2025), per Business Quant data.